The largest database of trusted experimental protocols
> Chemicals & Drugs > Organic Chemical > Oxaloacetate

Oxaloacetate

Oxaloacetate is a key metabolic intermediate in the citric acid cycle, playing a crucial role in energy production and carbon metabolism within cells.
This four-carbon dicarboxylic acid serves as a substrate for the enzyme malate dehydrogenase, enabling the reversible conversion between oxaloacetate and malate.
Oxaloacetate is also involved in gluconeogenesis, amino acid synthesis, and other vital biochemical processes.
Understainding the regulation and dynamics of oxaloacetate is essential for researchers studying cellular energetics, metabolic disorders, and potential therapeutic interventions targeting these pathways.
PubCompare.ai offers a powerful AI-driven platform to optimize oxloacetae research by locating the most reliable protocols from literature, preprints, and patents, while providing accurate comparisons to identify the best experimental options.
Enhance your research reproducibiltiy and accuracy with the tools availabe on PubCompare.ai.

Most cited protocols related to «Oxaloacetate»

We reconstructed the metabolic network of lysine producing C. glutamicum based on published information [39 (link)] and additional modelling details kindly provided by the authors [see Additional file 2]. The input substrate used was [1-13C]-glucose (with 99% enrichment purity), and all fluxes were normalized with respect to the glucose uptake rate (i.e., fluxes are expressed in percentage of glucose uptake rate). As the published MIDs are uncorrected, all the simulated EMU variables were modified for mass interference from non-carbon backbone isotopes using the molecular formula of the amino acids fragments (i.e., parent ion cluster). The first n+1 signal elements were normalized (n indicates number of backbone carbon), and then truncated to the correct vector length (equivalent to the measured MIDs) before performing weighted least-square analysis. The inferred metabolic model consisted of a total of 71 reactions and 42 balanceable metabolites. The metabolite model yielded a total of 26 degrees-of-freedom and 18 fluxes were determined experimentally: anabolic precursor yields (11), biomass yield (1), secreted product yields (5), and glucose uptake rate (1). To reduce the number of unknown parameters, these 18 fluxes were chosen as free fluxes, and the associated flux values were used deterministically as no redundant data exist in the measurement set. Note that if one suspects gross measurement errors in the flux measurement set, then these fluxes should be set free and the flux values subjected to the least-square analysis together with the MIDs. Five (5) of the remaining 8 free fluxes are associated with the reversibility of non-oxidative pentose-phosphate pathway enzymes (3), glucose-6P isomerase (1) and intercellular CO2 exchange (1). The other 3 free fluxes were assigned (by the software) to the irreversible fluxes of glucose-6P dehydrogenase, pyruvate carboxylase, and glycine synthesis via the serine route.
The MID of 9 amino acids and trehalose were reported. Three "S" type reactions were included in the metabolite network to directly map label distribution of alanine, aspartate and glutamate to pyruvate, oxaloacetate and α-ketoglutarate, respectively. This was not necessary for all other amino acids and trehalose because these metabolites were already described in the isotopomer balances.
Full text: Click here
Publication 2009
Alanine alpha-Ketoglutaric Acid Amino Acids Anabolism Androgens, Synthetic Aspartate Carbon Carbon Isotopes Cloning Vectors Enzymes Glucose Glucose Dehydrogenase glucose isomerase Glutamates Glycine Lysine Metabolic Networks Oxaloacetate Parent Pentose Phosphate Pathway Pyruvate Pyruvate Carboxylase Serine Trehalose Vertebral Column
Whole-body glucose turnover was measured by determining the specific activity of glucose in the steady-state plasma using a scintillation counter. Hepatic glucose production was assumed to represent ∼90% of the measured whole-body glucose turnover based on our previously published data (7 (link)). Liver-specific metabolic flux rates were calculated using a combined NMR-LC-MS/MS method. We corrected for the natural abundance of each metabolite included in the flux calculations, measuring all possible enrichments (for instance, m+0, m+1, m+2, m+3, and m+4 for malate) and correcting the measured peak areas to account for the fact that once a carbon is labeled it can no longer contribute to the natural abundance (10 (link)). Samples were prepared for NMR by homogenizing 2–3 g of liver in 5 volumes of 7% perchloric acid. The pH of the samples was adjusted to 6.8–7.3 using 30% potassium hydroxide and 7% perchloric acid as necessary, and the samples were centrifuged at 4000 × g for 10 min. The supernatant was frozen in liquid N2 and lyophilized. 13C NMR analysis was performed as described by Befroy et al. (6 (link)). Total glucose and alanine enrichment was measured by GC/MS and glutamate by LC-MS/MS, with 13C NMR used to algebraically divide the total enrichment to determine the enrichment of each carbon of these metabolites.
We calculated the [2-13C]malate enrichment by relating the positional enrichments of malate to those measured in glutamate assuming (and validating) full equilibration across fumarase as shown in Equations 1 and 2.


For calculation of the liver-specific metabolic flux ratio VPyr-Cyc/VMito = (VPK + VME, out)/(VPC + VME, in+ VPDH), we used our previously published isotopic labeling model (6 (link), 7 (link)) extended using a mass isotopomer multiordinate spectral analysis approach to take into account VPK and unlabeled mass entry from propionate at the succinyl-CoA step of the TCA cycle (10 (link)). Here, VME, out refers to ME flux in the direction of pyruvate synthesis; VME, in refers to the reverse reaction of pyruvate into malate, and VLDH refers to pyruvate synthesis via LDH. With these fluxes taken into account, we can describe the steady-state mass balance at pyruvate with Equation 3,
and isotope balance at [2-13C]pyruvate with Equation 4,

Because the positional enrichments of pyruvate and PEP cannot be measured reliably using our NMR-LC-MS/MS techniques, we use the following label substitutions shown in Equations 5 and 6,


Substituting Equations 5 and 6 into Equation 4 and rearranging, we derive Equation 7,

By separating out like terms, we get Equation 8,
where VPDH denotes flux through pyruvate dehydrogenase; VCS denotes flux through citrate synthase; VPK denotes flux through pyruvate kinase; VME, out denotes flux through malic enzyme from malate to pyruvate; VME, in denotes flux through malic enzyme from pyruvate to malate; and VPC denotes flux through pyruvate carboxylase. Additional fluxes shown in the complete flux diagram in Fig. 1 are VGNG OAA gluconeogenesis from oxaloacetate, VGNG total gluconeogenesis, and Vprop the rate of propionate entry into the TCA cycle. VPDH/VCS was measured using the ratio [4-13C]glutamate/[3-13C]alanine, as described by Alves et al. (11 (link)).
Full text: Click here
Publication 2016
Alanine Anabolism Carbon Carbon-13 Magnetic Resonance Spectroscopy Citrate (si)-Synthase Citric Acid Cycle Freezing Fumarate Hydratase Gas Chromatography-Mass Spectrometry Gluconeogenesis Glucose Glutamates Human Body Isotopes Liver malate Oxaloacetate Oxidoreductase Perchloric Acid Plasma potassium hydroxide Propionate Pyruvate Pyruvate Carboxylase Pyruvate Kinase pyruvic-malic carboxylase Scintillation Counters succinyl-coenzyme A Tandem Mass Spectrometry
Absolute values of intracellular fluxes were calculated with a flux model comprising all the major pathways of yeast central carbon metabolism (Additional data file 2). Deleted reactions were not omitted from the mutant models; thus the mutations were independently verified from the 13C data. The stoichiometric matrix of 34 linear equations and 30 metabolites has an infinite condition number [57 (link)]; it is thus underdetermined, and has a solution space with an infinite number of different flux vectors that fulfill the constraints from determined uptake and production rates. To uniquely solve the system for fluxes (ν), a set of linearly independent equations that quantify flux ratios (FlRs) were used to obtain eight constraints on the relative flux distribution from METAFoR analysis (see Additional data file 2).
The fraction of cytosolic oxaloacetate originating from cytosolic pyruvate is given by:
The fraction of mitochondrial oxaloacetate derived through anaplerosis is given by:
The fraction of PEP originating from cytosolic oxaloacetate is given by:
The fraction of serine derived through glycolysis is given by:
The upper and lower bounds for mitochondrial pyruvate derived through the malic enzyme (from mitochondrial malate) are given by:
The contribution of glycine to serine biosynthesis is given by:
and, finally, the contribution of serine to glycine biosynthesis is given by:
The stoichiometric matrix including Equations 3-10 has a condition number of 31, implying that the model is numerically robust [57 (link)]. Error minimization was carried out as described by Fischer et al. [10 (link)]. Balanced NADPH production and consumption were not added as additional constraints. In general, NADPH production was constrained by Equations 3 and 7/8, which estimate the relative use of the PP pathway and malic enzyme, respectively. As an additional source of NADPH, the flux through the NADPH-dependent acetaldehyde dehydrogenase [33 (link)] was estimated from the acetate production rate and the biomass requirement for cytosolic acetyl-CoA. Deviation of the NADPH production estimated in this way from the consumption for biosynthesis was generally below ± 20%, suggesting that the model assumptions and the experimental data are highly consistent. All extreme flux patterns were independently verified in 30-ml cultures (data not shown).
Full text: Click here
Publication 2005
Acetaldehyde acetaldehyde dehydrogenase Acetate Anabolism Carbon Cloning Vectors Coenzyme A, Acetyl Cytosol Glycine Glycolysis malate Metabolism Mitochondria Mutation NADP NADPH Dehydrogenase Oxaloacetate Protoplasm Pyruvate pyruvic-malic carboxylase Saccharomyces cerevisiae Serine

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
Adenine Nucleotides Anabolism Antimycin A Azides Biopharmaceuticals Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone Cardiac Arrest Cell Respiration Cells Citrate Coenzyme A, Acetyl Cytochromes Digitonin duroquinol Electrons Electron Transport Electron Transport Complex III Ethanol Fatty Acids Glutamates Glycogen Branching Enzyme inhibitors malate Membrane Potential, Mitochondrial Mitochondria Mitochondrial Membrane, Inner NADH NADH Dehydrogenase Complex 1 Oxaloacetate Oxidase, Cytochrome-c Oxidative Phosphorylation Oxidoreductase Oxygen Oxygen Consumption Palmitoylcarnitine Phosphorylation Protons Pyruvate Rotenone SDHD protein, human Skeletal Myocytes Succinate Tetramethylphenylenediamine Titrimetry ubidecarenone

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2017
3-phosphoglycerate Alanine alpha-Ketoglutaric Acid Aspartate Carbon Carbon Sequestration Citrate Citrate (si)-Synthase Citric Acid Cycle Coenzyme A, Acetyl Cytosol Fumarate Gas Chromatography-Mass Spectrometry Glucose Glutamates Glutamine Glycogen Hypersensitivity Isotopes Lactates Lipogenesis malate Metabolic Flux Analysis Metabolism Mitochondria Neoplasms Oxaloacetate Phosphoenolpyruvate Plasma Protoplasm Pyruvate Succinate

Most recents protocols related to «Oxaloacetate»

Example 2

A 28 year-old woman experienced severe anger and depression one day a month, right before her period, every month. She took two capsules of 100 mg anhydrous enol-oxaloacetate on that day. She reported that while the anger and depression were not completely resolved, they were reduced in intensity to the point where she could manage the symptoms easily.

Full text: Click here
Patent 2024
Anger Capsule Oxaloacetate Woman
Not available on PMC !

Example 1

In a clinical trial, 30 women with PMS were first evaluated for PMS and then presented with the nutritional supplement “benaGene” (100 mg anhydrous enol-oxaloacetate with a pharmaceutically acceptable excipient of 150 mg anhydrous ascorbic acid). Only one patient did not report a substantial improvement, indicative of a positive response rate of 97%. Typically, in 30-60 minutes from taking 1 to 2 capsules, once per day, many or all PMS symptoms would either resolve fully or would be reduced significantly. The patients would only take the supplement during days they experienced PMS symptoms, and not the rest of the month. 3 capsules did not produce a superior response to 2 capsules.

Full text: Click here
Patent 2024
Ascorbic Acid Capsule Dietary Supplements Excipients Oxaloacetate Patients PMS-1 Woman

Example 6

A 25-year old woman presented with severe anxiety attacks and fatigue during the week before menstruation. At the start of these panic attacks or during extreme fatigue, she placed two lozenges of 100 mg anhydrous enol-oxaloacetate with a suitable pH adjustment and pharmaceutical carrier under her tongue for 5 minutes. The panic attack subsided in less than 5 minutes and fatigue was greatly reduced.

Full text: Click here
Patent 2024
Anxiety Fatigue Menstruation Oxaloacetate Panic Attacks Pharmaceutical Preparations Tongue Woman

Example 5

A woman presented with severe PMDD ever since she was 13 years old. She is now 26. Typically, the patient had to take-off from work 3 days out of each month, and self-seclude, because she could not be with people. She started taking 2 capsules benaGene (each 100 mg anhydrous enol-oxaloacetate with acceptable pharmacological carriers). All symptoms resolved and she no longer has to take off from work. The improvements with anhydrous enol-oxaloacetate have continued for over 2 years with this patient.

Full text: Click here
Patent 2024
Capsule Oxaloacetate Patients Premenstrual Dysphoric Disorder Woman
Adult 8-week-old female CD1 mice were purchased from the Charles River Laboratory (Wilmington, MA, RRID: IMSR_CRL:22). Mice were anesthetized with 1%–5% isoflurane gas with continuous inhalation. The second and fourth digits of both hind limbs were amputated at the P3 distal level as previously described and regenerating digits were collected at days 14, 21, 28, and 42 for analysis (Sammarco et al., 2015 (link); Busse et al., 2019 (link); Hoffseth et al., 2021a (link); Hoffseth et al., 2021b (link); Tower et al., 2022 (link)). The third digit was used as an unamputated control. Oxaloacetate (OAA) (Sigma, 07753) was dissolved in saline (PBS) and pH-adjusted with NaOH to 7.0 to allow the OAA solution to drift toward alkaline levels as previously described (Tower et al., 2022 (link)), with the exception that mice were treated daily with 1 g/kg OAA in 200 µL via i.p. injection. The vehicle-treated group received saline. Mice were dosed from day 10 until day 28. Dichloroacetate (DCA) (Alfa, B21897) was dissolved in PBS. Mice were treated daily with 0.05 g/kg DCA (Liang et al., 2020 (link)) in 100 µL via i.p. injection. The vehicle treated group received PBS.
Full text: Click here
Publication 2023
Fingers Inhalation Isoflurane Mice, House Oxaloacetate Rivers Saline Solution Woman

Top products related to «Oxaloacetate»

Sourced in United States
Oxaloacetate is a chemical compound that serves as an important intermediate in the tricarboxylic acid (TCA) cycle, also known as the citric acid cycle. It plays a crucial role in cellular metabolism, particularly in the conversion of acetyl-CoA into energy-rich molecules. Oxaloacetate is a key component in the process of cellular respiration and energy production.
Sourced in United States, Germany, United Kingdom, Denmark, France, Austria, Japan, Italy, Macao, China
Pyruvate is a chemical compound that serves as an intermediate in various metabolic pathways. It is a key product of glycolysis and can be further metabolized through different processes, such as the citric acid cycle or lactate production. Pyruvate is a versatile molecule that plays a central role in cellular energy production and various biochemical reactions.
Sourced in United States, Germany, United Kingdom, Macao
Malate is a laboratory instrument used to measure the concentration of malate, a dicarboxylic acid, in various samples. It provides quantitative analysis of malate levels in biological, food, and environmental samples.
Sourced in United States, Germany
Citrate is a salt or ester of citric acid, a compound found naturally in citrus fruits. It is commonly used in various laboratory applications as a buffer, chelating agent, and preservative. Citrate helps maintain the pH and ionic balance of solutions, and can also bind to metal ions to prevent interference in analytical procedures.
Sourced in United Kingdom
Alpha-ketoglutarate is a chemical compound that serves as an important intermediate in the citric acid cycle, a metabolic pathway that plays a crucial role in cellular respiration. It is a key component in the production of energy within cells.
Sourced in United States
D-2-hydroxyglutarate is a chemical compound used in laboratory research. It serves as a metabolic intermediate in various biological processes. The compound can be utilized in analytical and experimental procedures, though its specific applications may vary depending on the research context.
Sourced in United States, Germany, China, United Kingdom, Italy, Japan, Sao Tome and Principe, France, Canada, Macao, Switzerland, Spain, Australia, Israel, Hungary, Ireland, Denmark, Brazil, Poland, India, Mexico, Senegal, Netherlands, Singapore
The Protease Inhibitor Cocktail is a laboratory product designed to inhibit the activity of proteases, which are enzymes that can degrade proteins. It is a combination of various chemical compounds that work to prevent the breakdown of proteins in biological samples, allowing for more accurate analysis and preservation of protein integrity.
Sourced in United States, United Kingdom, Germany, China, Japan
The SpectraMax Plus 384 is a high-performance microplate reader that provides precise and reliable absorbance, fluorescence, and luminescence measurements. It features a 384-well microplate format, enabling efficient and high-throughput assays. The instrument offers a wide range of wavelengths, making it suitable for a variety of applications in life science research and drug discovery.
Sourced in United States
L-malate is a chemical compound that functions as a laboratory reagent. It is used in various analytical and experimental applications within scientific research and testing environments.
Sourced in United States
D-malate is a laboratory equipment product. It functions as a chemical reagent for analytical and research purposes.

More about "Oxaloacetate"

Oxaloacetate is a crucial metabolic intermediate in the citric acid cycle, also known as the tricarboxylic acid (TCA) cycle or Krebs cycle.
This four-carbon dicarboxylic acid plays a vital role in energy production and carbon metabolism within cells.
Oxaloacetate serves as a substrate for the enzyme malate dehydrogenase, enabling the reversible conversion between oxaloacetate and malate, an important step in the TCA cycle.
Beyond its central role in the citric acid cycle, oxaloacetate is also involved in other essential biochemical processes, such as gluconeogenesis (the synthesis of glucose from non-carbohydrate precursors) and amino acid synthesis.
Understanding the regulation and dynamics of oxaloacetate is crucial for researchers studying cellular energetics, metabolic disorders, and potential therapeutic interventions targeting these pathways.
Related terms and concepts include pyruvate (a precursor to oxaloacetate), malate (a product of the oxaloacetate-malate conversion), citrate (another key TCA cycle intermediate), alpha-ketoglutarate (a related TCA cycle metabolite), and D-2-hydroxyglutarate (a potential biomarker for certain metabolic disorders).
Protease inhibitor cocktails and the SpectraMax Plus 384 microplate reader are also relevant tools and techniques used in oxaloacetate research.
Whether you're investigating the role of oxaloacetate in energy production, exploring its involvement in metabolic pathways, or searching for potential therapeutic targets, PubCompare.ai offers a powerful AI-driven platform to optimize your research.
Our tools can help you locate the most reliable protocols from literature, preprints, and patents, while providing accurate comparisons to identify the best experimental options.
Enhance your research reproducibility and accuracy with the resources available on PubCompare.ai.